Mauro Salizzoni

Azienda Ospedaliera Citta' della Salute e della Scienza di Torino — Italy

Medicine · Health Sciences

55h-index14.5kcitations411works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Organ Transplantation Techniques and Outcomes(163), Liver Disease and Transplantation(134), Liver Disease Diagnosis and Treatment(121), Hepatitis C virus research(84), Hepatitis B Virus Studies(59)

Publications411 total

Long-term outcomes and health-related quality of life 20 years after pediatric liver transplantation
Updates in Surgery·2023· 11 citedOpen Access
Supplementary Table S3 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023Open Access
Supplementary Table S2 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023Open Access
Supplementary Materials and Methods from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023Open Access
Data from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023Open Access
Supplementary Table S1 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023Open Access
Supplementary Table S6 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023Open Access
Supplementary Figure S1 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023Open Access
Supplementary Table S5 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023Open Access
Supplementary Table S7 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023Open Access
Supplementary Table S4 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023Open Access
Data from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023Open Access
Supplementary Table S6 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023Open Access
Supplementary Table S2 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023Open Access
Supplementary Table S3 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023Open Access
Supplementary Table S5 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023Open Access
Supplementary Table S7 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023Open Access
Supplementary Table S1 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023Open Access
Supplementary Figure S1 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023Open Access
Supplementary Table S4 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023Open Access
page 1 of 21Next →

Frequent Co-authors

Renato Romagnoli(14), A Franchello(10), Luciano De Carlis(9), Vincenzo Mazzaferro(8), René Adam(8), Vincent Karam(8), Jan Lerut(7), Jürgen Klempnauer(7), Ezio David(7), P. Neuhaus(6), Umberto Cillo(6), Massimo Rossi(6), M. Colledan(6), Fausto Zamboni(6), Andrew K. Burroughs(5), Alfredo Marzano(5), Giovanni Camussi(5), S. Agnes(5), Mario Rizzetto(4), Darius F. Mirza(4)